Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cardioprotective and metabolic effects of metformin in heart failure and type 2 diabetes
2012-001390-88Phase 4Completed
- Sponsor
- Institute for Clinical and Experimental Medicine
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of metformin in type 2 diabetes mellitus (T2DM) and chronic heart failure (CHF), sponsored by Institute for Clinical and Experimental Medicine. Primary endpoint: Causal link between insulin resistance and exercise intolerance in heart failure. Started Mar 2012; status: completed.
02
Drugs
metformin
03
Conditions
type 2 diabetes mellitus (T2DM)chronic heart failure (CHF)
Beyond the preview
Go deeper on 2012-001390-88.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001390-88.